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AnnexinIn the majority of cells, the integrity of the plasmalemma is recurrently compromised bymechanical or chemical
stress. Serum complement or bacterial pore-forming toxins can perforate the plasma membrane provoking un-
controlled Ca2+ inﬂux, loss of cytoplasmic constituents and cell lysis. Plasmalemmal blebbing has previously
been shown to protect cells against bacterial pore-forming toxins. The activation of the P2X7 receptor
(P2X7R), an ATP-gated trimeric membrane cation channel, triggers Ca2+ inﬂux and induces blebbing. We have
investigated the role of the P2X7R as a regulator of plasmalemmal protection after toxin-inducedmembrane per-
foration caused by bacterial streptolysin O (SLO).
Our results show that the expression and activation of the P2X7R furnishes cells with an increased chance of sur-
viving attacks by SLO. This protective effect can be demonstratednot only inhuman embryonic kidney 293 (HEK)
cells transfectedwith the P2X7R, but also in humanmast cells (HMC-1), which express the receptor endogenous-
ly. In addition, this effect is abolished by treatment with blebbistatin or A-438079, a selective P2X7R antagonist.
Thus blebbing, which is elicited by the ATP-mediated, paracrine activation of the P2X7R, is part of a cellular non-
immune defense mechanism. It pre-empts plasmalemmal damage and promotes cellular survival. This mecha-
nism is of considerable importance for cells of the immune systemwhich carry the P2X7R and which are specif-
ically exposed to toxin attacks.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Serum complement or bacterial pore-forming toxins perforate the
plasma membrane of a host cell and cause inﬂux of extracellular —
and efﬂux of cytoplasmic components, which might lead to cell death
[1–4]. It is thus not surprising that eukaryotic cells have developed
membrane repair mechanisms and adapted them to suit the nature
and severity of plasmalemmal injury [5,8]. A breakdown of the Ca2+
concentration gradient between cytoplasm and extracellular milieu
serves as an indicator of plasmalemmal disruption and acts asmolecular
guidance for the intracellular repair machinery. Intracellular [Ca2+] ele-
vations are recognized by Ca2+ sensors such as proteins of the annexin
family, which bind Ca2+-dependently to negatively-charged phospho-
lipids [9] and have been ascribed a role in plasmalemmal repair [10,13].
Blebbing – a temporary detachment of the lipid bilayer from the
submembranous cytoskeleton – is considered to be an early sign of in-
tracellular Ca2+ elevation, which indicates imminent or incipientmem-
brane injury [14]. We have recently proposed blebbing to be a damage-
controlmechanism,which is triggered after the failure of plasmalemmal; HMC-1, humanmast cell line 1;
ysin O
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ights reserved.resealing [15]. The ability to bleb provides a clear beneﬁt of survival for a
cell confronted with attacks on its plasmalemma by pore-forming
toxins [15].
Since P2X7R activation is associated with an increase in membrane
blebbing [16], we have investigated the role of this receptor as a molec-
ular regulator of plasmamembrane protection after plasmalemmal per-
foration caused by the bacterial toxin SLO. The ionotropic P2X7R has
two transmembrane domains; intracellular NH2- and COOH-termini
and forms a homotrimer [17]. It is ubiquitously expressed, with high
levels in immune cells and exists as a multiprotein complex, including
the non-muscle myosin heavy chains and other cytoskeletal elements
[18,19]. The activation of the P2X7R by extracellular ATP opens a cation-
ic channelwhich gradually dilates to a larger pore [20,22]. It is itself sub-
ject to regulation by numerous polymorphic variants and isoforms
which increase or decrease its efﬁciency [23]. In macrophages primed
by lipopolysaccharide, channel opening is additionally associated with
the secretion of pro-inﬂammatory cytokines IL-1β [24,25] and IL-18
[26,27]. P2X7R activation is followed by downstream effects such as
blebbing [28,29], microvesicle shedding [30,31], cell fusion [32], prolif-
eration [33] and eventually cell death [34]. Furthermore, in the absence
of ATP, P2X7R plays a role in recognition and phagocytosis of foreign
particles [35,36].
We demonstrate that the expression of the P2X7R confers resistance
to the attack by bacterial pore-forming toxins. This protective effect can
be increased by activation of the P2X7R with ATP and is abolished by
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nist. We further suggest that the paracrine activation of this receptor by
ATP, released by damaged neighboring cells, initiates blebbing and thus
induces resistance to toxin-induced cell lysis. Blebbing is a characteristic
feature of injured cells. It is thus conceivable that cells – in particular
within inﬂammatory foci – use this ATP-triggered, P2X7R-mediated
warning system to alert their neighbors to an approaching wave of
bacterial toxins.
2. Materials and methods
2.1. Cell culture
HEK cells were maintained in DMEM (Dulbecco's modiﬁed Eagle's
medium), containing 2 mM glutamax, 100 U/ml penicillin, 100 μg/ml
streptomycin and 10% fetal calf serum (FCS) andwere transfected as de-
scribed [11,37]. HEK cells stably transfected with the rat P2X7R
(HEKrtP2X7) or the human P2X7R (HEKhuP2X7) [38] were cultured
in DMEM/F12 medium supplemented with 2 mM glutamax, G418
(300 μg/ml), 2 mM MgCl2 and 10% FCS. HMC-1 were cultured in
IMDM with 10% FCS, 100 U/ml penicillin and 100 μg/ml streptomycin
as described [39]. All cellswere grown in 5%CO2 at 37 °C in a humidiﬁed
incubator. For the viability experiments, the cells were challenged with
750 U/ml SLO from Streptococcus pyogenes (Sigma-Aldrich, Buchs,
Switzerland) in Tyrode's buffer (140 mM NaCl, 5 mM KCl, 1 mM
MgCl2, 10 mM glucose, 10 mM HEPES; pH = 7.4) containing 2.5 mM
CaCl2 or 1mMEGTA (for the experimentwithout extracellular calcium)
for 15 min at room temperature (RT). Cell viability was quantiﬁed by
the cell health indicator alamarBlue® following the manufacturer's in-
structions (Life Technologies, Carlsbad, USA [40]). To inhibit P2X7R-
speciﬁc ATP stimulation, the cells were incubated with 1 μM or 10 μM
A-438079 (Sigma-Aldrich, Buchs, Switzerland) for 15 min at RT.
2.2. Expression of annexins as fusions with ﬂuorescent proteins
The coding sequences of annexins A1 and A2 were cloned into the
Living Colors Fluorescent protein vectors pEGFP-N1 or pEYFP-N1
(Clontech, Saint-Germain-en-Laye, France) following PCR ampliﬁcation
from human bladder smoothmuscle cDNA. The ﬂuorescent protein was
attached to the C-terminus of the annexins, which has been shown not
to affect the protein function [41]. The oligonucleotide pairs used for
PCR correspond to the N-termini (forward) and C-termini (reverse,
lacking the stop codon) of annexins and contain appropriate restriction
sites to allow the in-frame cloning with ﬂuorescent proteins.
For annexin A1, 5′-TTTAAGCTAGCGATGGCAATGGTATCAGATTCCTC-3′
forward and 3′TTATTCTGCAGGTTTCCTCCAAACAGAGCCAC-5′ reverse.
For annexinA2, 5′-AATATAGCTAGCATGTCTACTGTTCACGAAATCCTG-3′
forward and 5′ATAAACTCGAGTTAGTATAGGCTTTGACAGAC-3′ reverse.
2.3. Imaging
Glass coverslips with annexin-expressing HEK cells were mounted in
a perfusion chamber at RT in Tyrode's buffer containing 2.5 mM CaCl2.
To induce blebbing, the ATP analog 2′(3′)-O-(4-Benzoylbenzoyl)ATP
(BzATP) was added to the cells at concentrations between 10 μM and
100 μM (in Tyrode's buffer). Cell lysis was monitored by irreversible
elevation of intracellular [Ca2+] above 20 μM using permanent
plasmalemmal translocation of annexin A1 as a read-out [15]. Cells
were challenged with 750 U/ml SLO in Tyrode's buffer for 15 min at
RT. When indicated, the cells were pretreated with blebbistatin
(100 μM, 30 min) and/or ATP (30 μM, 10–15 min) before the addition
of SLO. The ﬂuorescencewas recorded in an Axiovert 200Mmicroscope
with a laser scanning module LSM 510 META (Carl Zeiss AG, Feldbach,
Switzerland) using a 63× oil immersion lens. The imageswere analyzed
using the ‘Zeiss LSM Image examiner’ software package (Carl Zeiss AG).
To determine the percentage of lysis, the number of cells with annexinA1 translocation was divided by the total cell number [15]. Transient
plasmalemmal translocations of ﬂuorescently-labeled annexin A2
were used to monitor elevations of intracellular Ca2+ in the lowmicro-
molar range [11,42].
Numerical data are expressed as mean values together with the
standard error. The statistical analyses were performed using GraphPad
Prism 5.04 andMicrosoft Excel 2010. The level of signiﬁcance was set at
P b 0.05. Signiﬁcant differences are marked with asterisks.
2.4. Western blotting
HEK, HEKrtP2X7 andHEKhuP2X7 cellswere resuspended in SDS sam-
ple buffer (200 mM Tris–HCl, 40 mM EGTA, pH 7, 3.1% SDS, 7.7% β-
mercaptoethanol, 13.4% glycerol and 60 μg/ml of bromophenol blue)
and boiled for 1 min. Samples were run on 8% SDS–polyacrylamide
minigels together with a molecular weight marker (Page Ruler
Prestained, Thermo Scientiﬁc, Erembodegem, Belgium). Equal amounts
of proteinwere loaded for the different protein extracts as estimated by
a test gel. Blotting was carried out overnight onto a PVDF membrane
(Millipore AG, Zug, Switzerland). Unspeciﬁc binding sites were blocked
with 4% non-fat drymilk in low salt buffer (0.9% NaCl, 10mMTris-Base,
0.1% Tween 20) for 1 h at RT. Primary antibodies (polyclonal rabbit-
anti-P2X7R, Alomone Labs, Jerusalem, Israel) were diluted in low salt
buffer supplemented with 2% non-fat milk powder and incubated for 1
h at RT. The blot waswashed 3 timeswith low salt buffer for 10min. Sec-
ondary antibodies (HRP-donkey-anti-rabbit IgG, GE Healthcare,
Glattbrugg, Switzerland) were diluted in low salt buffer supplemented
with 2% non-fat milk powder and incubated for 45 min at RT. Finally,
the blotwaswashed again 3 timeswith low salt buffer for 10min. Chemi-
luminescence reaction was performed using Western Bright ECL from
Advansta (Menlo Park, CA, USA) and the signal was detected by a Fusion
FX imaging system (Vilber Lourmat, Marne-la-Vallée, France).
3. Results
In order to investigate P2X7R function in plasmalemmal repair, we
initially applied a well characterized model system (HEK cells), in
which blebbing has previously been associated with increased survival
[15]. We conﬁrmed that the transcription (Fig. 1A) and protein expres-
sion (Fig. 1B) of P2X7R occurred in HEK cells stably transfectedwith the
P2X7R gene, but not in control cells. Immunostaining with antibodies
against the P2X7R demonstrated that it was localized to the plasmalem-
ma, as previously described, whereas untransfected HEK cells were de-
void of signal (Fig. 1C).
The activation of a functional P2X7R leads to an increase in [Ca2+],
followed by blebbing [43,44]. Therefore, the functionality of the P2X7R
in stably transfected HEK cells was established by stimulation with in-
creasing concentrations of BzATP [45] and by simultaneous monitoring
of blebbing activity and [Ca2+] by Ca2+-dependent plasmalemmal
translocation of ﬂuorescently labeled annexin A2 [11].
HEKrtP2X7 cells responded to increasing concentrations of BzATP by
an increased plasmalemmal blebbing (Fig. 2A). After stimulation with
10 μM BzATP, 2.4 ± 1.8% of the cells blebbed, whereas at 30 μM
BzATP, ~50% of the cells displayed blebbing during 1 h of treatment.
At a concentration of 100 μM BzATP, almost all cells blebbed (98.6 ±
1.4%; 450 cells on 30 slides, Supplementary Movie 1).
Annexin A2 reversibly translocates between the cytoplasm and the
plasmalemma at low micromolar [Ca2+]i [42]. In non-stimulated cells,
annexin A2 localizes within the cytoplasm [11]; this pattern was not al-
tered by the expression of the P2X7R. Blebbing closely correlated with
annexin A2 membrane translocation, conﬁrming Ca2+ inﬂux through
the opened P2X7 channel after stimulationwith BzATP (Fig. 2B). Stimu-
lation with 30 μM BzATP led to increased blebbing (Fig. 2C) and
plasmalemmal translocation of annexin A2 (Fig. 2D) in 64.5 ± 8.1% of
cells (495 cells on 33 slides).
Fig. 1. Expression and localization of the P2X7R in stably transfected HEK cells. (A) qRT-PCR analysis of P2X7R expression conﬁrms its presence only in the stably transfected cell
line (rtP2X7). (B) Western blot analysis of HEK (1–2), HEKrtP2X7 (3–4) and HEKhuP2X7 (5–6) cells shows the P2X7R to be present only in the transfected cell lines (columns 3–6).
β-Actin was used as loading control. (C) A confocal micrograph of HEKrtP2X7 cells (left picture) immunolabeled with an antibody against the P2X7R (green) and DAPI (red) reveals
the plasmalemmal localization of the receptor. HEK cells (right picture) do not show any membrane labeling. Scale bar = 10 μm.
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toxin-induced lysis was analyzed bymonitoring irreversible membrane
translocation of YFP-annexin A1 ([Ca2+]i-elevation above 20 μM) [15].
Fig. 3A shows that the expression of the P2X7R alone confers resistance
against SLO toxicity. HEKrtP2X7 cells showed a signiﬁcantly lower
amount of SLO-induced lysis (59.5% ± 6.4%, t-test: P b 0.001; 147 cells
on 11 slides) compared to the wild-type cells (100% ± 4.8%, 187 cells
on 13 slides). As expected, the P2X7R stimulation with ATP prior
to toxin incubation led to an additional reduction of lysis (Fig. 3B;
24.4% ± 7.7%, t-test: P b 0.01, 277 cells on 14 slides). Representative
confocal micrographs depict the extent of annexin A1 translocation
during the experimental conditions described above (Fig. 3C).
To elucidate the role of Ca2+ in the protective effect of the P2X7R,we
performed alamarBlue® cell viability assays [40]. In the presence of ex-
tracellular Ca2+, an increased viability was observed in HEKrtP2X7 cells
compared to non-transfected HEK cells (Fig. 3D). Correspondingly, we
could detect signiﬁcantly more blebbing in HEKrtP2X7 cells comparedto HEK cells (44.5 ± 9.9% versus 27.1 ± 4.7%) after SLO-treatment
(Fig. 3E). Such protective effectwas lacking in the absence of extracellu-
lar Ca2+ and the viability after treatment with SLO at Ca2+-free condi-
tions was drastically reduced in both cell types.
Our data demonstrate that the P2X7R has a protective effect, which
is dependent on the extracellular [Ca2+], even without activation by
ATP. Ca2+ ions can enter the cells through the SLO pores and trigger
blebbing by activating contraction of myosin II [46]. The increase in
blebbing in HEKrtP2X7 cells compared to HEK cells even without stim-
ulation by ATP may be a consequence of the increased ability of the
endoplasmatic reticulum (ER) to accumulate, store and release Ca2+
[47]. Consequently, the Ca2+ inﬂux via toxin pores might potentiate
Ca2+ release from the ER, leading to a larger increase in cytosolic
[Ca2+] in P2X7R transfected cells resulting in stronger blebbing.
We next investigated whether membrane blebbing was responsible
for the protection against lysis. Blebbing – and its concomitant positive
effect on cellular survival mediated by the P2X7R – was inhibited by
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an agent that is known to interact with non-muscle myosin II and to in-
hibit blebbing [48].
To determine if ATP is a P2X7R-speciﬁc mediator of this process, we
treated HEKrtP2X7 cells with A-438079, a selective P2X7R antagonist,
which reversibly blocks rat and human P2X7R and inhibits BzATP in-
duced IL-1β release as well as pore formation [49]. Pretreatment with
A-438079 before the incubation with ATP (30 μM) and SLO treatment,
led to a complete abolishment of the ATP-mediated protective effect
(Fig. 5A; 33 measurements in 3 independent AlamarBlue® assays).
The physiological signiﬁcance of our ﬁndings were emphasized in
experiments with HMC-1, which express the P2X7R endogenously
[50]. Viability was signiﬁcantly increased after pretreatment of the
mast cells with ATP prior to toxin exposure (Fig. 5B; from 17.7 ± 1.3%
to 32.1 ± 1.6%; 34 measurements in 3 independent assays) and
abolished by pretreatment with A-438079.
4. Discussion
The P2X7R has been proposed to function as a regulator of inﬂam-
mation [51]. In systemic illnesses such as rheumatoid arthritis, the acti-
vation of the P2X7R is associated with an increase in the secretion ofproinﬂammatory cytokines and an exacerbation of the disease [52]. Its
prolonged activation leads to apoptotic cell death [53] and its absence
has been linked to a diminished output of inﬂammatory mediators
such as IL-1 [54]. ATP is considered a physiological ligand of the
P2X7R, which in vivo is released from viable or dying cells or from
degranulating platelets [55,57]. In view of its effect on neighboring
cells, ATP has been identiﬁed as an endogenous danger signal with po-
tentially detrimental effects when it is released into the extracellular
space after tissue damage [58].
Numerous studies have addressed the frequently deleterious conse-
quences for an organism, which is ﬂooded with proinﬂammatory cyto-
kines following P2X7R activation [52,58]. Conversely, the absence or
loss-of-function of the P2X7R has been shown to diminish cellular
host defenses against pathogens such as Chlamydia [59] or Toxoplasma
gondii [60].
Our study addresses the role of P2X7R activation in the survival of
cells subjected to an attack by bacterial toxins. Exposed to an often un-
favorable environment and threatened by the exposure to bacterial
toxins, cellular survival is critically dependent on an early warning sys-
tem in combination with efﬁcient plasmalemmal repair.
Plasmalemmal repair can be achieved by different Ca2+-dependent
mechanisms: eukaryotic cells are capable of patching injured regions
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cytosis [5] or of resealing the plasma membrane by endocytosis of the
damaged sites [6,61]. Microparticle shedding has been shown to play
a role in the quarantining and elimination of injured plasmalemmal re-
gions [8,62].
Previous studies have associated enhanced P2X7R activity with
plasmalemmal blebbing [21,63] and microvesicle shedding [30] as
well as with the death of injured cells [14,64]. In addition, blebs also
play a role in cellular migration [46,65,66]. We have recently proposed
that blebs confer resistance to toxin-induced plasmalemmal injury by
acting as a trap for the damaged membrane region, which is sealed off
from the cell body [15].
Proteins of the annexin family are able to sense elevated [Ca2+]i [42].
In the presence of Ca2+, annexin A1 aggregates and fuses biologicalmembranes [9,67,69]. Exposed to a strong ﬂux of Ca2+ in the vicinity
of a toxin pore, annexin A1 binds to the plasmalemma within the bleb
and cross-links the adjacent membranes of its slender neck, thus
forming a plug that creates two separate compartments. This process
enables the cell to repair its plasmalemma within the bleb without en-
dangering the cell body. After membrane integrity has been restored
and Ca2+ homeostasis has been re-established, annexin A1 translocates
back to the cytoplasm thereby dissolving the plug [13].
Stimulation of the P2X7R (by ATP or its analog BzATP) leads to the
opening of a cation channel [21] and Ca2+ inﬂux, which initiates bleb-
bing [28] andmicroparticle release [30]. Our data show that the expres-
sion of the P2X7R alone improves the survival of cells during attacks by
the pore-forming bacterial toxin SLO. This protective effect is evenmore
pronounced if the receptor is stimulated with its physiological ligand
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pretreatment with blebbistatin or a speciﬁc P2X7R antagonist.
5. Conclusions
Plasmalemmal blebbing constitutes an intricate cellular defense sys-
tem: on the one hand, blebbing allows the cell to isolate the damaged
plasmalemmal segment and protects the cell body from further injury0.0%
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Fig. 6. The role of blebbing as a non-immune defense mechanism. Blebbing provides spa-
tially conﬁned compartments inwhichmembrane repair can take place (left cell). ATP re-
leased from damaged cells serves as a paracrine signal, alerting neighboring cells by
activation of the P2X7R followed by blebbing (right cell).
921R. Schoenauer et al. / Biochimica et Biophysica Acta 1843 (2014) 915–922Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.01.024.
Acknowledgements
WethankAndreaHostettler for her excellent technical assistance. This
study was supported by grants from the Swiss National Science Founda-
tion (SNF) to AD (320030_128064/1) and EB (3100A0_121980/1).
Images were acquired on equipment supported by the Microscopy
Imaging Center of the University of Bern.
References
[1] B.P. Morgan, J.P. Luzio, A.K. Campbell, Intracellular Ca2+ and cell injury: a paradox-
ical role of Ca2+ in complement membrane attack, Cell Calcium 7 (1986) 399–411.
[2] M.D. Geeraerts, M.F. Ronveaux-Dupal, J.J. Lemasters, B. Herman, Cytosolic free Ca2+
and proteolysis in lethal oxidative injury in endothelial cells, Am. J. Physiol. 261
(1991) C889–C896.
[3] M.W. Parker, S.C. Feil, Pore-forming protein toxins: from structure to function, Prog.
Biophys. Mol. Biol. 88 (2005) 91–142.
[4] M.R. Gonzalez, M. Bischofberger, L. Pernot, F.G. van der Goot, B. Freche, Bacterial
pore-forming toxins: the (w)hole story? Cell. Mol. Life Sci. 65 (2008) 493–507.
[5] P.L. McNeil, R.A. Steinhardt, Plasma membrane disruption: repair, prevention, adap-
tation, Annu. Rev. Cell Dev. Biol. 19 (2003) 697–731.
[6] C.S. Eddleman, M.L. Ballinger, M.E. Smyers, C.M. Godell, H.M. Fishman, G.D. Bittner,
Repair of plasmalemmal lesions by vesicles, Proc. Natl. Acad. Sci. U. S. A. 94 (1997)
4745–4750.
[7] P.L. McNeil, T. Kirchhausen, An emergency response team formembrane repair, Nat.
Rev. Mol. Cell Biol. 6 (2005) 499–505.
[8] E.B. Babiychuk, K.Monastyrskaya, S. Potez, A. Draeger, Intracellular Ca(2+) operates
a switch between repair and lysis of streptolysin O-perforated cells, Cell Death
Differ. 16 (2009) 1126–1134.
[9] V. Gerke, S.E. Moss, Annexins and membrane dynamics, Biochim. Biophys. Acta
1357 (1997) 129–154.
[10] V. Gerke, S.E. Moss, Annexins: from structure to function, Physiol. Rev. 82 (2002)
331–371.
[11] K. Monastyrskaya, E.B. Babiychuk, A. Hostettler, U. Rescher, A. Draeger, Annexins as
intracellular calcium sensors, Cell Calcium 41 (2007) 207–219.
[12] A. Bouter, C. Gounou, R. Berat, S. Tan, B. Gallois, T. Granier, B.L. d'Estaintot, E. Poschl,
B. Brachvogel, A.R. Brisson, Annexin-A5 assembled into two-dimensional arrays pro-
motes cell membrane repair, Nat. Commun. 2 (2011) 270.
[13] A. Draeger, K. Monastyrskaya, E.B. Babiychuk, Plasma membrane repair and cellular
damage control: the annexin survival kit, Biochem. Pharmacol. 81 (2011) 703–712.
[14] P. Nicotera, P. Hartzell, G. Davis, S. Orrenius, The formation of plasma membrane blebs
in hepatocytes exposed to agents that increase cytosolic Ca2+ is mediated by the acti-
vation of a non-lysosomal proteolytic system, FEBS Lett. 209 (1986) 139–144.
[15] E.B. Babiychuk, K. Monastyrskaya, S. Potez, A. Draeger, Blebbing confers resistance
against cell lysis, Cell Death Differ. 18 (2011) 80–89.
[16] C. Virginio, A. MacKenzie, F.A. Rassendren, R.A. North, A. Surprenant, Pore dilation of
neuronal P2X receptor channels, Nat. Neurosci. 2 (1999) 315–321.[17] T. Kawate, J.C. Michel, W.T. Birdsong, E. Gouaux, Crystal structure of the ATP-gated
P2X(4) ion channel in the closed state, Nature 460 (2009) 592–598.
[18] B.J. Gu, C. Rathsam, L. Stokes, A.B.McGeachie, J.S.Wiley, Extracellular ATP dissociates
nonmuscle myosin from P2X(7) complex: this dissociation regulates P2X(7) pore
formation, Am. J. Physiol. Cell Physiol. 297 (2009) C430–C439.
[19] M. Kim, L.H. Jiang, H.L. Wilson, R.A. North, A. Surprenant, Proteomic and func-
tional evidence for a P2X7 receptor signalling complex, EMBO J. 20 (2001)
6347–6358.
[20] R.A. North, Molecular physiology of P2X receptors, Physiol. Rev. 82 (2002)
1013–1067.
[21] C. Virginio, A. MacKenzie, R.A. North, A. Surprenant, Kinetics of cell lysis, dye uptake
and permeability changes in cells expressing the rat P2X7 receptor, J. Physiol. 519
(Pt 2) (1999) 335–346.
[22] P. Pelegrin, A. Surprenant, The P2X(7) receptor-pannexin connection to dye uptake
and IL-1beta release, Purinergic Signal 5 (2009) 129–137.
[23] B. Cheewatrakoolpong, H. Gilchrest, J.C. Anthes, S. Greenfeder, Identiﬁcation and
characterization of splice variants of the human P2X7 ATP channel, Biochem.
Biophys. Res. Commun. 332 (2005) 17–27.
[24] M. Solle, J. Labasi, D.G. Perregaux, E. Stam, N. Petrushova, B.H. Koller, R.J. Grifﬁths,
C.A. Gabel, Altered cytokine production in mice lacking P2X(7) receptors, J. Biol.
Chem. 276 (2001) 125–132.
[25] D. Ferrari, C. Pizzirani, E. Adinolﬁ, R.M. Lemoli, A. Curti, M. Idzko, E. Panther, F. Di
Virgilio, The P2X7 receptor: a key player in IL-1 processing and release, J. Immunol.
176 (2006) 3877–3883.
[26] D.G. Perregaux, P. McNiff, R. Laliberte, M. Conklyn, C.A. Gabel, ATP acts as an agonist
to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood,
J. Immunol. 165 (2000) 4615–4623.
[27] A. Piccini, S. Carta, S. Tassi, D. Lasiglie, G. Fossati, A. Rubartelli, ATP is released by
monocytes stimulated with pathogen-sensing receptor ligands and induces
IL-1beta and IL-18 secretion in an autocrine way, Proc. Natl. Acad. Sci. U. S. A. 105
(2008) 8067–8072.
[28] H.L. Wilson, S.A.Wilson, A. Surprenant, R.A. North, Epithelial membrane proteins in-
duce membrane blebbing and interact with the P2X7 receptor C terminus, J. Biol.
Chem. 277 (2002) 34017–34023.
[29] P.A. Verhoef, M. Estacion, W. Schilling, G.R. Dubyak, P2X7 receptor-dependent bleb-
bing and the activation of Rho-effector kinases, caspases, and IL-1 beta release,
J. Immunol. 170 (2003) 5728–5738.
[30] A. MacKenzie, H.L. Wilson, E. Kiss-Toth, S.K. Dower, R.A. North, A. Surprenant, Rapid
secretion of interleukin-1beta by microvesicle shedding, Immunity 15 (2001)
825–835.
[31] Y. Qu, L. Franchi, G. Nunez, G.R. Dubyak, Nonclassical IL-1 beta secretion stimu-
lated by P2X7 receptors is dependent on inﬂammasome activation and correlat-
ed with exosome release in murine macrophages, J. Immunol. 179 (2007)
1913–1925.
[32] P. Chiozzi, J.M. Sanz, D. Ferrari, S. Falzoni, A. Aleotti, G.N. Buell, G. Collo, F. Di Virgilio,
Spontaneous cell fusion in macrophage cultures expressing high levels of the
P2Z/P2X7 receptor, J. Cell Biol. 138 (1997) 697–706.
[33] O.R. Baricordi, L. Melchiorri, E. Adinolﬁ, S. Falzoni, P. Chiozzi, G. Buell, F. Di Virgilio,
Increased proliferation rate of lymphoid cells transfected with the P2X(7) ATP re-
ceptor, J. Biol. Chem. 274 (1999) 33206–33208.
[34] D. Ferrari, P. Chiozzi, S. Falzoni, M. Dal Susino, G. Collo, G. Buell, F. Di Virgilio,
ATP-mediated cytotoxicity in microglial cells, Neuropharmacology 36 (1997)
1295–1301.
[35] B.J. Gu, B.M. Saunders, C. Jursik, J.S. Wiley, The P2X7-nonmuscle myosin membrane
complex regulates phagocytosis of nonopsonized particles and bacteria by a path-
way attenuated by extracellular ATP, Blood 115 (2010) 1621–1631.
[36] J.S.Wiley, B.J. Gu, A new role for the P2X7 receptor: a scavenger receptor for bacteria
and apoptotic cells in the absence of serum and extracellular ATP, Purinergic Signal
8 (2012) 579–586.
[37] A. Surprenant, F. Rassendren, E. Kawashima, R.A. North, G. Buell, The cytolytic P2Z
receptor for extracellular ATP identiﬁed as a P2X receptor (P2X7), Science 272
(1996) 735–738.
[38] B.D. Humphreys, C. Virginio, A. Surprenant, J. Rice, G.R. Dubyak, Isoquinolines as an-
tagonists of the P2X7 nucleotide receptor: high selectivity for the human versus rat
receptor homologues, Mol. Pharmacol. 54 (1998) 22–32.
[39] F. Hollins, D. Kaur, W. Yang, G. Cruse, R. Saunders, A. Sutcliffe, P. Berger, A. Ito, C.E.
Brightling, P. Bradding, Human airway smooth muscle promotes human lung mast
cell survival, proliferation, and constitutive activation: cooperative roles for CADM1,
stem cell factor, and IL-6, J. Immunol. 181 (2008) 2772–2780.
[40] S. Al-Nasiry, N. Geusens, M. Hanssens, C. Luyten, R. Pijnenborg, The use of Alamar
Blue assay for quantitative analysis of viability, migration and invasion of choriocar-
cinoma cells, Hum. Reprod. 22 (2007) 1304–1309.
[41] U. Rescher, N. Zobiack, V. Gerke, Intact Ca(2+)-binding sites are required for
targeting of annexin 1 to endosomal membranes in living HeLa cells, J. Cell Sci.
113 (Pt 22) (2000) 3931–3938.
[42] A. Draeger, S. Wray, E.B. Babiychuk, Domain architecture of the smooth-muscle plas-
ma membrane: regulation by annexins, Biochem. J. 387 (2005) 309–314.
[43] P. Ballerini, M.P. Rathbone, P. Di Iorio, A. Renzetti, P. Giuliani, I. D'Alimonte, O.
Trubiani, F. Caciagli, R. Ciccarelli, Rat astroglial P2Z (P2X7) receptors regulate intra-
cellular calcium and purine release, Neuroreport 7 (1996) 2533–2537.
[44] A. Morelli, P. Chiozzi, A. Chiesa, D. Ferrari, J.M. Sanz, S. Falzoni, P. Pinton, R. Rizzuto,
M.F. Olson, F. Di Virgilio, Extracellular ATP causes ROCK I-dependent bleb formation
in P2X7-transfected HEK293 cells, Mol. Biol. Cell 14 (2003) 2655–2664.
[45] M.T. Young, P. Pelegrin, A. Surprenant, Amino acid residues in the P2X7 receptor
that mediate differential sensitivity to ATP and BzATP, Mol. Pharmacol. 71 (2007)
92–100.
922 R. Schoenauer et al. / Biochimica et Biophysica Acta 1843 (2014) 915–922[46] G. Charras, E. Paluch, Blebs lead the way: how to migrate without lamellipodia, Nat.
Rev. Mol. Cell Biol. 9 (2008) 730–736.
[47] E. Adinolﬁ, M.G. Callegari, M. Cirillo, P. Pinton, C. Giorgi, D. Cavagna, R. Rizzuto, F. Di
Virgilio, Expression of the P2X7 receptor increases the Ca2+ content of the endo-
plasmic reticulum, activates NFATc1, and protects from apoptosis, J. Biol. Chem.
284 (2009) 10120–10128.
[48] A.F. Straight, A. Cheung, J. Limouze, I. Chen, N.J. Westwood, J.R. Sellers, T.J. Mitchison,
Dissecting temporal and spatial control of cytokinesis with a myosin II Inhibitor,
Science 299 (2003) 1743–1747.
[49] D.L. Donnelly-Roberts, M.F. Jarvis, Discovery of P2X7 receptor-selective antagonists
offers new insights into P2X7 receptor function and indicates a role in chronic
pain states, Br. J. Pharmacol. 151 (2007) 571–579.
[50] E.S. Schulman, M.C. Glaum, T. Post, Y. Wang, D.G. Raible, J. Mohanty, J.H. Butterﬁeld,
A. Pelleg, ATP modulates anti-IgE-induced release of histamine from human lung
mast cells, Am. J. Respir. Cell Mol. Biol. 20 (1999) 530–537.
[51] J.M. Sanz, F. Di Virgilio, Kinetics and mechanism of ATP-dependent IL-1 beta release
from microglial cells, J. Immunol. 164 (2000) 4893–4898.
[52] A. Al-Shukaili, J. Al-Kaabi, B. Hassan, A comparative study of interleukin-1beta pro-
duction and p2x7 expression after ATP stimulation by peripheral blood mononucle-
ar cells isolated from rheumatoid arthritis patients and normal healthy controls,
Inﬂammation 31 (2008) 84–90.
[53] J.S. Wiley, R. Sluyter, B.J. Gu, L. Stokes, S.J. Fuller, The human P2X7 receptor and its
role in innate immunity, Tissue Antigens 78 (2011) 321–332.
[54] J.M. Labasi, N. Petrushova, C. Donovan, S.McCurdy, P. Lira,M.M. Payette,W. Brissette,
J.R. Wicks, L. Audoly, C.A. Gabel, Absence of the P2X7 receptor alters leukocyte func-
tion and attenuates an inﬂammatory response, J. Immunol. 168 (2002) 6436–6445.
[55] E.M. Schwiebert, ABC transporter-facilitated ATP conductive transport, Am. J. Phys-
iol. 276 (1999) C1–C8.
[56] Y. Oshimi, S. Miyazaki, S. Oda, ATP-induced Ca2+ response mediated by P2U and
P2Y purinoceptors in human macrophages: signalling from dying cells to macro-
phages, Immunology 98 (1999) 220–227.
[57] R. Beigi, E. Kobatake, M. Aizawa, G.R. Dubyak, Detection of local ATP release from ac-
tivated platelets using cell surface-attached ﬁreﬂy luciferase, Am. J. Physiol. 276
(1999) C267–C278.[58] K. Wilhelm, J. Ganesan, T. Muller, C. Durr, M. Grimm, A. Beilhack, C.D. Krempl, S.
Sorichter, U.V. Gerlach, E. Juttner, A. Zerweck, F. Gartner, P. Pellegatti, F. Di Virgilio,
D. Ferrari, N. Kambham, P. Fisch, J. Finke, M. Idzko, R. Zeiser, Graft-versus-host
disease is enhanced by extracellular ATP activating P2X7R, Nat. Med. 16 (2010)
1434–1438.
[59] R. Coutinho-Silva, L. Stahl, M.N. Raymond, T. Jungas, P. Verbeke, G. Burnstock, T.
Darville, D.M. Ojcius, Inhibition of chlamydial infectious activity due to P2X7R-
dependent phospholipase D activation, Immunity 19 (2003) 403–412.
[60] M.P. Lees, S.J. Fuller, R. McLeod, N.R. Boulter, C.M. Miller, A.M. Zakrzewski, E.J. Mui,
W.H. Witola, J.J. Coyne, A.C. Hargrave, S.E. Jamieson, J.M. Blackwell, J.S. Wiley, N.C.
Smith, P2X7 receptor-mediated killing of an intracellular parasite, Toxoplasma
gondii, by human and murine macrophages, J. Immunol. 184 (2010) 7040–7046.
[61] V. Idone, C. Tam, J.W.Goss, D. Toomre,M. Pypaert, N.W.Andrews, Repair of injuredplas-
mamembrane by rapid Ca2+-dependent endocytosis, J. Cell Biol. 180 (2008) 905–914.
[62] A. Piccin, W.G. Murphy, O.P. Smith, Circulating microparticles: pathophysiology and
clinical implications, Blood Rev. 21 (2007) 157–171.
[63] Y. Qu, G.R. Dubyak, P2X7 receptors regulate multiple types of membrane trafﬁcking
responses and non-classical secretion pathways, Purinergic Signal 5 (2009) 163–173.
[64] C. Segundo, F. Medina, C. Rodriguez, R. Martinez-Palencia, F. Leyva-Cobian, J.A.
Brieva, Surface molecule loss and bleb formation by human germinal center B cells
undergoing apoptosis: role of apoptotic blebs in monocyte chemotaxis, Blood 94
(1999) 1012–1020.
[65] G.T. Charras, A short history of blebbing, J. Microsc. 231 (2008) 466–478.
[66] O.T. Fackler, R. Grosse, Cell motility through plasma membrane blebbing, J. Cell Biol.
181 (2008) 879–884.
[67] A.K. McNeil, U. Rescher, V. Gerke, P.L. McNeil, Requirement for annexin A1 in plasma
membrane repair, J. Biol. Chem. 281 (2006) 35202–35207.
[68] P. Raynal, H.B. Pollard, Annexins: the problem of assessing the biological role for a
gene family of multifunctional calcium- and phospholipid-binding proteins,
Biochim. Biophys. Acta 1197 (1994) 63–93.
[69] A. Rosengarth, H. Luecke, A calcium-driven conformational switch of the N-terminal
and core domains of annexin A1, J. Mol. Biol. 326 (2003) 1317–1325.
[70] G. Collo, S. Neidhart, E. Kawashima, M. Kosco-Vilbois, R.A. North, G. Buell, Tissue dis-
tribution of the P2X7 receptor, Neuropharmacology 36 (1997) 1277–1283.
